Cover Image

The importance of LDL-C lowering in atherosclerotic cardiovascular disease prevention: Lower for longer is better

Cumulative exposure to low-density lipoprotein cholesterol (LDL-C) is a key driver of atherosclerotic cardiovascular disease (ASCVD) risk. An armamentarium of therapies to achieve robust and sustained reduction in LDL-C can reduce ASCVD risk. The gold standard for LDL-C assessment is ultracentrifuga...

Full description

Saved in:

Bibliographic Details
Main Authors:	Omar Mhaimeed (Author), Zain A Burney (Author), Stacey L Schott (Author), Payal Kohli (Author), Francoise A Marvel (Author), Seth S Martin (Author)
Format:	Book
Published:	Elsevier, 2024-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Longer Brace Duration Is Associated with Lower Stress Levels and Better Quality of Life in Adolescents with Idiopathic Scoliosis
by: Fabrizio Di Maria, et al.
Published: (2023)

Cardiovascular mortality after intensive LDL-Cholesterol lowering: Does baseline LDL-Cholesterol really matter?
by: Safi U. Khan, et al.
Published: (2020)

New and emerging lipid-modifying drugs to lower LDL cholesterol
by: Constantine E Kosmas, et al.
Published: (2021)

Is lower better? Is lowest the best?
by: Lale Tokgözoğlu
Published: (2017)

Moving toward combination lipid-lowering therapy for all patients with atherosclerotic cardiovascular disease
by: Kamil F. Faridi, et al.
Published: (2023)

Beyond Statins: Novel Lipid-Lowering Agents for Reducing Risk of Atherosclerotic Cardiovascular Disease
by: Teimur Kayani, et al.
Published: (2024)

Geographic variations in lipid-lowering therapy utilization, LDL-C levels, and proportion retrospectively meeting the ACC/AHA very high-risk criteria in a real-world population of patients with major atherosclerotic cardiovascular disease events in the United States
by: Seth J. Baum, et al.
Published: (2021)

Working longer goes with working in better conditions
by: Alexis Descatha
Published: (2023)

Lifelong prevention of atherosclerotic cardiovascular disease (ASCVD) through LDL-C control - Means and cost/benefit of sustained very low lifetime LDL-C targets
by: Mayank Dalakoti, et al.
Published: (2024)

Alphataxin, an Orally Available Small Molecule, Decreases LDL Levels in Mice as a Surrogate for the LDL-Lowering Activity of Alpha-1 Antitrypsin in Humans
by: Cynthia L. Bristow, et al.
Published: (2021)

Erratum to "Cardiovascular Mortality after Intensive LDL-Cholesterol Lowering: Does Baseline LDL-Cholesterol Really Matter?" [American Journal of Preventive Cardiology 1C (2020) 100013]
by: Safi U. Khan, et al.
Published: (2021)

Remote and Anesthetic-Induced Myocardial Preconditioning Is Preserved in Atherosclerotic LDL Receptor-/- Mice In Vivo
by: Walter Petermichl, et al.
Published: (2021)

Training the Lower Body for Better Stances, Steps, & Kicks
by: Allen Pittman
Published: (2012)

Subpopulations of regulatory T cells are associated with subclinical atherosclerotic plaques, levels of LDL, and cardiorespiratory fitness in the elderly
by: Tim Böttrich, et al.
Published: (2024)

Longer Multimorbidity Intervals Are Associated With Lower Mortality in Diabetes: A Whole-Population Nested Case-Control Study
by: Wenlong Liu, et al.
Published: (2024)

A Mechanistic Systems Pharmacology Model for Prediction of LDL Cholesterol Lowering by PCSK9 Antagonism in Human Dyslipidemic Populations
by: K Gadkar, et al.
Published: (2014)

HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (HOFH) REQUIRES QUADRUPLE LIPID-LOWERING THERAPY TO ACHIEVE APPROPRIATELY LOW LDL-C
by: Viet Trung Le, DMSc, PA-C
Published: (2024)

Dicarbonyl-Dependent Modification of LDL as a Key Factor of Endothelial Dysfunction and Atherosclerotic Vascular Wall Damage
by: Vadim Z. Lankin, et al.
Published: (2022)

Atherosclerotic coronary plaque regression from lipid-lowering therapies: A meta-analysis and meta-regression
by: Frederick Berro Rivera, et al.
Published: (2024)

Temporal trends and racial/ethnic- and sex-differences in LDL cholesterol control among US adults with self-reported atherosclerotic cardiovascular disease
by: Danh Q. Nguyen, et al.
Published: (2024)

Lower fat and better quality diet therapy for children with pharmacoresistant epilepsy
by: Jung-Rim Yoon, et al.
Published: (2013)

Lipid-lowering therapy and LDL-C control for primary prevention in persons with diabetes across 90 health systems in the United States
by: Emily Decicco, et al.
Published: (2023)

Lipid-lowering therapy for primary prevention of premature atherosclerotic coronary artery disease: Eligibility, utilization, target achievement, and predictors of initiation
by: Diana N. Vikulova, et al.
Published: (2020)

Daily Treatment with Traditional Korean Medicine and a Longer Hospitalization Period Aids Recovery in Patients with Lower Back Pain Sustained in Road Traffic Accidents
by: Je-Heon Noh, et al.
Published: (2018)

Regulatory effect of Phikud Navakot extract on HMG-CoA reductase and LDL-R: potential and alternate agents for lowering blood cholesterol
by: Napatara Tirawanchai, et al.
Published: (2018)

Atherosclerotic Cardiovascular Disease
Published: (2011)

Efficacy of Mobile-Based Cognitive Behavioral Therapy on Lowering Low-density Lipoprotein Cholesterol Levels in Patients With Atherosclerotic Cardiovascular Disease: Multicenter, Prospective Randomized Controlled Trial
by: DuanBin Li, et al.
Published: (2023)

Low-density lipoprotein cholesterol outcomes post-non-PCSK9i lipid-lowering therapies in atherosclerotic cardiovascular disease and probable heterozygous familial hypercholesterolemia patients
by: Chen CC, et al.
Published: (2018)

Yellow Wine Polyphenolic Compounds Inhibit Matrix Metalloproteinase-2, -9 Expression and Improve Atherosclerotic Plaque in LDL-Receptor-Knockout Mice
by: Xiaoya Zhai, et al.
Published: (2014)

Cumulus matrix selection leads to isolation of spermatozoa with better motility, morphology, and lower DNA fragmentation
by: Maria Handzhiyska, et al.
Published: (2024)

Infantile appendicitis: Importance of diagnostic accuracy and a lowered threshold for computed tomography
by: Raymond Okeke, et al.
Published: (2022)

Migrant elders in Hainan, China, report better health and lower depression than local-born elderly residents
by: Wei Wang, et al.
Published: (2017)

Some Longer Elizabethan Poems
by: Bullen, A. H. (Arthur Henry), 1857-1920 [Author of introduction, etc.]; Seccombe, Thomas, 1866-1923 [Editor]

The Importance of Antihypertensive and Lipid-Lowering Therapy in the Treatment of Patients with a New Coronavirus Infection COVID-19
by: V. I. Podzolkov, et al.
Published: (2021)

Implementing an Innovative Lipid Management Technique Using siRNA LDL-C Lowering Therapy: Lessons Learned in an NHS Primary Care Practice With Worked Case Examples
by: Carl Deaney, et al.
Published: (2023)

Invasive Mechanical Ventilation and Death Was More Likely in Patients with Lower LDL Cholesterol Levels during COVID-19 Hospitalization: A Retrospective Propensity-Matched Cohort Study
by: Adhya Mehta, et al.
Published: (2023)

Lipid-Lowering Effects of Carob Extracts (Ceratonia siliqua): Proposed Mechanisms and Clinical Importance
by: Marko Nemet, et al.
Published: (2022)

THE IMPORTANCE OF VIRAL ETIOLOGY DETERMINATION IN SEVERE LOWER RESPIRATORY TRACT INFECTIONS IN INFANTS AND CHILDREN
by: Alexandru-Ioan Ulmeanu, et al.
Published: (2015)

Assessment of oxLDL, anti-oxLDL antibodies and lipoprotein-associated phospholipase A2 as cardiovascular risk markers in obese adolescents with and without T1DM
by: Nesreen N. Omar, et al.
Published: (2017)

Lower urinary tract symptoms are beyond lower urinary tract
by: Ming-Ping Wu
Published: (2015)